-
Je něco špatně v tomto záznamu ?
Deciphering the genetics and mechanisms of predisposition to multiple myeloma
M. Went, L. Duran-Lozano, GH. Halldorsson, A. Gunnell, N. Ugidos-Damboriena, P. Law, L. Ekdahl, A. Sud, G. Thorleifsson, M. Thodberg, T. Olafsdottir, A. Lamarca-Arrizabalaga, C. Cafaro, A. Niroula, R. Ajore, A. Lopez de Lapuente Portilla, Z. Ali,...
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
2017-02023
Vetenskapsrådet (Swedish Research Council)
2018-00424
Vetenskapsrådet (Swedish Research Council)
NLK
Directory of Open Access Journals
od 2015
Free Medical Journals
od 2010
Nature Open Access
od 2010-12-01
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2010-01-01
Open Access Digital Library
od 2015-01-01
Open Access Digital Library
od 2015-01-01
Medline Complete (EBSCOhost)
od 2012-11-01
Health & Medicine (ProQuest)
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
Springer Nature OA/Free Journals
od 2010-12-01
- MeSH
- B-lymfocyty imunologie metabolismus MeSH
- celogenomová asociační studie * MeSH
- genetická predispozice k nemoci * MeSH
- jednonukleotidový polymorfismus * MeSH
- lidé MeSH
- maturační antigen B-buněk * genetika MeSH
- mendelovská randomizace MeSH
- mnohočetný myelom * genetika MeSH
- receptor TACI genetika MeSH
- studie případů a kontrol MeSH
- telomery genetika MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Multiple myeloma (MM) is an incurable malignancy of plasma cells. Epidemiological studies indicate a substantial heritable component, but the underlying mechanisms remain unclear. Here, in a genome-wide association study totaling 10,906 cases and 366,221 controls, we identify 35 MM risk loci, 12 of which are novel. Through functional fine-mapping and Mendelian randomization, we uncover two causal mechanisms for inherited MM risk: longer telomeres; and elevated levels of B-cell maturation antigen (BCMA) and interleukin-5 receptor alpha (IL5RA) in plasma. The largest increase in BCMA and IL5RA levels is mediated by the risk variant rs34562254-A at TNFRSF13B. While individuals with loss-of-function variants in TNFRSF13B develop B-cell immunodeficiency, rs34562254-A exerts a gain-of-function effect, increasing MM risk through amplified B-cell responses. Our results represent an analysis of genetic MM predisposition, highlighting causal mechanisms contributing to MM development.
Broad Institute 415 Main Street Cambridge MA 02142 USA
Department of Hematology Erasmus MC Cancer Institute 3075 EA Rotterdam The Netherlands
Department of Integrative Medical Biology Umeå University SE 901 87 Umeå Sweden
Department of Internal Medicine 5 University of Heidelberg 69120 Heidelberg Germany
Department of Laboratory Medicine Lund University SE 221 84 Lund Sweden
Department of Radiation Sciences Umeå University SE 901 87 Umeå Sweden
Division of Genetics and Epidemiology The Institute of Cancer Research London SW7 3RP UK
eCODE Genetics Amgen Sturlugata 8 IS 101 Reykjavik Iceland
Faculty of Medicine in Pilsen Charles University 30605 Pilsen Czech Republic
Faculty of Medicine University of Iceland IS 101 Reykjavik Iceland
German Cancer Research Center D 69120 Heidelberg Germany
Hopp Children's Cancer Center Heidelberg Germany
Institute of Experimental Medicine Academy of Sciences of the Czech Republic Prague Czech Republic
Landspitali National University Hospital of Iceland IS 101 Reykjavik Iceland
Lund Stem Cell Center Lund University SE 221 84 Lund Sweden
MSB Medical School Berlin Berlin Germany
Myeloma Center University of Arkansas for Medical Sciences Little Rock AR USA
Perlmutter Cancer Center Langone Health New York University New York NY USA
Section of Hematology Sahlgrenska University Hospital Gothenburg SE 413 45 Sweden
Skåne University Hospital SE 221 85 Lund Sweden
Southern Älvsborg Hospital SE 501 82 Borås Sweden
University Hospital Ostrava and University of Ostrava Ostrava Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019398
- 003
- CZ-PrNML
- 005
- 20241024110736.0
- 007
- ta
- 008
- 241015s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41467-024-50932-7 $2 doi
- 035 __
- $a (PubMed)39103364
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Went, Molly $u Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK $1 https://orcid.org/000000033271975X
- 245 10
- $a Deciphering the genetics and mechanisms of predisposition to multiple myeloma / $c M. Went, L. Duran-Lozano, GH. Halldorsson, A. Gunnell, N. Ugidos-Damboriena, P. Law, L. Ekdahl, A. Sud, G. Thorleifsson, M. Thodberg, T. Olafsdottir, A. Lamarca-Arrizabalaga, C. Cafaro, A. Niroula, R. Ajore, A. Lopez de Lapuente Portilla, Z. Ali, M. Pertesi, H. Goldschmidt, L. Stefansdottir, SY. Kristinsson, SN. Stacey, TJ. Love, S. Rognvaldsson, R. Hajek, P. Vodicka, U. Pettersson-Kymmer, F. Späth, C. Schinke, F. Van Rhee, P. Sulem, E. Ferkingstad, G. Hjorleifsson Eldjarn, UH. Mellqvist, I. Jonsdottir, G. Morgan, P. Sonneveld, A. Waage, N. Weinhold, H. Thomsen, A. Försti, M. Hansson, A. Juul-Vangsted, U. Thorsteinsdottir, K. Hemminki, M. Kaiser, T. Rafnar, K. Stefansson, R. Houlston, B. Nilsson
- 520 9_
- $a Multiple myeloma (MM) is an incurable malignancy of plasma cells. Epidemiological studies indicate a substantial heritable component, but the underlying mechanisms remain unclear. Here, in a genome-wide association study totaling 10,906 cases and 366,221 controls, we identify 35 MM risk loci, 12 of which are novel. Through functional fine-mapping and Mendelian randomization, we uncover two causal mechanisms for inherited MM risk: longer telomeres; and elevated levels of B-cell maturation antigen (BCMA) and interleukin-5 receptor alpha (IL5RA) in plasma. The largest increase in BCMA and IL5RA levels is mediated by the risk variant rs34562254-A at TNFRSF13B. While individuals with loss-of-function variants in TNFRSF13B develop B-cell immunodeficiency, rs34562254-A exerts a gain-of-function effect, increasing MM risk through amplified B-cell responses. Our results represent an analysis of genetic MM predisposition, highlighting causal mechanisms contributing to MM development.
- 650 12
- $a mnohočetný myelom $x genetika $7 D009101
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a genetická predispozice k nemoci $7 D020022
- 650 12
- $a celogenomová asociační studie $7 D055106
- 650 12
- $a maturační antigen B-buněk $x genetika $7 D053301
- 650 12
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a mendelovská randomizace $7 D057182
- 650 _2
- $a B-lymfocyty $x imunologie $x metabolismus $7 D001402
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a receptor TACI $x genetika $7 D053303
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a telomery $x genetika $7 D016615
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Duran-Lozano, Laura $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden
- 700 1_
- $a Halldorsson, Gisli H $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland $1 https://orcid.org/0000000170679862
- 700 1_
- $a Gunnell, Andrea $u Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK $1 https://orcid.org/0000000151625391
- 700 1_
- $a Ugidos-Damboriena, Nerea $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden
- 700 1_
- $a Law, Philip $u Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK $1 https://orcid.org/0000000196634611
- 700 1_
- $a Ekdahl, Ludvig $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden
- 700 1_
- $a Sud, Amit $u Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK $1 https://orcid.org/0000000261330164
- 700 1_
- $a Thorleifsson, Gudmar $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland $1 https://orcid.org/0000000346239087
- 700 1_
- $a Thodberg, Malte $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden $1 https://orcid.org/0000000162443841
- 700 1_
- $a Olafsdottir, Thorunn $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland $1 https://orcid.org/000000015454938X
- 700 1_
- $a Lamarca-Arrizabalaga, Antton $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden $1 https://orcid.org/0009000834262347
- 700 1_
- $a Cafaro, Caterina $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden
- 700 1_
- $a Niroula, Abhishek $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden $1 https://orcid.org/0000000259040635
- 700 1_
- $a Ajore, Ram $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden
- 700 1_
- $a Lopez de Lapuente Portilla, Aitzkoa $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden
- 700 1_
- $a Ali, Zain $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden
- 700 1_
- $a Pertesi, Maroulio $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden $1 https://orcid.org/0000000248698925
- 700 1_
- $a Goldschmidt, Hartmut $u Department of Internal Medicine V, University of Heidelberg, 69120, Heidelberg, Germany $1 https://orcid.org/0000000309610035
- 700 1_
- $a Stefansdottir, Lilja $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland
- 700 1_
- $a Kristinsson, Sigurdur Y $u Landspitali, National University Hospital of Iceland, IS-101, Reykjavik, Iceland $u Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland
- 700 1_
- $a Stacey, Simon N $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland $1 https://orcid.org/0000000247327380
- 700 1_
- $a Love, Thorvardur J $u Landspitali, National University Hospital of Iceland, IS-101, Reykjavik, Iceland $u Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland
- 700 1_
- $a Rognvaldsson, Saemundur $u Landspitali, National University Hospital of Iceland, IS-101, Reykjavik, Iceland $u Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland
- 700 1_
- $a Hajek, Roman $u University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000169556267 $7 nlk20000083645
- 700 1_
- $a Vodicka, Pavel $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Pettersson-Kymmer, Ulrika $u Department of Integrative Medical Biology, Umeå University, SE-901 87, Umeå, Sweden $1 https://orcid.org/0000000205579803
- 700 1_
- $a Späth, Florentin $u Department of Radiation Sciences, Umeå University, SE-901 87, Umeå, Sweden
- 700 1_
- $a Schinke, Carolina $u Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA $1 https://orcid.org/0000000226991741
- 700 1_
- $a Van Rhee, Frits $u Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA $1 https://orcid.org/0000000199591282
- 700 1_
- $a Sulem, Patrick $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland $1 https://orcid.org/0000000171236123
- 700 1_
- $a Ferkingstad, Egil $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland $1 https://orcid.org/0000000180907988
- 700 1_
- $a Hjorleifsson Eldjarn, Grimur $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland $1 https://orcid.org/0000000295806685
- 700 1_
- $a Mellqvist, Ulf-Henrik $u Southern Älvsborg Hospital, SE-501 82, Borås, Sweden
- 700 1_
- $a Jonsdottir, Ingileif $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland $1 https://orcid.org/000000018339150X
- 700 1_
- $a Morgan, Gareth $u Perlmutter Cancer Center, Langone Health, New York University, New York, NY, USA $1 https://orcid.org/0000000242716360
- 700 1_
- $a Sonneveld, Pieter $u Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands
- 700 1_
- $a Waage, Anders $u Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Box 8905, N-7491, Trondheim, Norway $1 https://orcid.org/0000000190721220
- 700 1_
- $a Weinhold, Niels $u Department of Internal Medicine V, University of Heidelberg, 69120, Heidelberg, Germany $u German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany
- 700 1_
- $a Thomsen, Hauke $u MSB Medical School Berlin, Berlin, Germany
- 700 1_
- $a Försti, Asta $u German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany $u Hopp Children's Cancer Center, Heidelberg, Germany $1 https://orcid.org/0000000298574728
- 700 1_
- $a Hansson, Markus $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden $u Section of Hematology, Sahlgrenska University Hospital, Gothenburg, SE-413 45, Sweden $u Skåne University Hospital, SE-221 85, Lund, Sweden $1 https://orcid.org/0000000277154548
- 700 1_
- $a Juul-Vangsted, Annette $u Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark $1 https://orcid.org/000000022131731X
- 700 1_
- $a Thorsteinsdottir, Unnur $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland $u Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland
- 700 1_
- $a Hemminki, Kari $u German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany $u Faculty of Medicine in Pilsen, Charles University, 30605, Pilsen, Czech Republic
- 700 1_
- $a Kaiser, Martin $u Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK $1 https://orcid.org/0000000236774804
- 700 1_
- $a Rafnar, Thorunn $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland $1 https://orcid.org/0000000304917046
- 700 1_
- $a Stefansson, Kari $u deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland $u Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland $1 https://orcid.org/000000031676864X
- 700 1_
- $a Houlston, Richard $u Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk $1 https://orcid.org/0000000252680242
- 700 1_
- $a Nilsson, Björn $u Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden. bjorn.nilsson@med.lu.se $u Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden. bjorn.nilsson@med.lu.se $u Broad Institute, 415 Main Street, Cambridge, MA, 02142, USA. bjorn.nilsson@med.lu.se $1 https://orcid.org/0000000155420254
- 773 0_
- $w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 15, č. 1 (2024), s. 6644
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39103364 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024110730 $b ABA008
- 999 __
- $a ok $b bmc $g 2201935 $s 1231371
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 15 $c 1 $d 6644 $e 20240805 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
- GRA __
- $a 2017-02023 $p Vetenskapsrådet (Swedish Research Council)
- GRA __
- $a 2018-00424 $p Vetenskapsrådet (Swedish Research Council)
- LZP __
- $a Pubmed-20241015